1170 related articles for article (PubMed ID: 30007970)
1. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
2. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
3. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
[TBL] [Abstract][Full Text] [Related]
4. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
[TBL] [Abstract][Full Text] [Related]
5. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice.
Liu TY; Xiong XQ; Ren XS; Zhao MX; Shi CX; Wang JJ; Zhou YB; Zhang F; Han Y; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012
[TBL] [Abstract][Full Text] [Related]
6. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
[TBL] [Abstract][Full Text] [Related]
8. Metformin ameliorates activation of hepatic stellate cells and hepatic fibrosis by succinate and GPR91 inhibition.
Nguyen G; Park SY; Le CT; Park WS; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Jan; 495(4):2649-2656. PubMed ID: 29278707
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic role of FNDC5/irisin in attenuating liver fibrosis via inhibiting release of hepatic stellate cell-derived exosomes.
Liao X; Luo Y; Gu F; Song W; Nie X; Yang Q
Hepatol Int; 2023 Dec; 17(6):1659-1671. PubMed ID: 37046114
[TBL] [Abstract][Full Text] [Related]
10. MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.
George J; Tsutsumi M; Tsuchishima M
J Cell Mol Med; 2017 Dec; 21(12):3821-3835. PubMed ID: 28782260
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA
Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605
[TBL] [Abstract][Full Text] [Related]
12. Succinate induces hepatic fibrogenesis by promoting activation, proliferation, and migration, and inhibiting apoptosis of hepatic stellate cells.
Park SY; Le CT; Sung KY; Choi DH; Cho EH
Biochem Biophys Res Commun; 2018 Feb; 496(2):673-678. PubMed ID: 29366478
[TBL] [Abstract][Full Text] [Related]
13. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-β.
Kawelke N; Vasel M; Sens C; Au Av; Dooley S; Nakchbandi IA
PLoS One; 2011; 6(11):e28181. PubMed ID: 22140539
[TBL] [Abstract][Full Text] [Related]
15. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity.
Xiong XQ; Geng Z; Zhou B; Zhang F; Han Y; Zhou YB; Wang JJ; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
Metabolism; 2018 Jun; 83():31-41. PubMed ID: 29374559
[TBL] [Abstract][Full Text] [Related]
16. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
17. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
18. Antifibrotic effects of protocatechuic aldehyde on experimental liver fibrosis.
Li C; Jiang W; Zhu H; Hou J
Pharm Biol; 2012 Apr; 50(4):413-9. PubMed ID: 22129045
[TBL] [Abstract][Full Text] [Related]
19. Sestrin 2 Attenuates Rat Hepatic Stellate Cell (HSC) Activation and Liver Fibrosis via an mTOR/AMPK-Dependent Mechanism.
Hu YB; Ye XT; Zhou QQ; Fu RQ
Cell Physiol Biochem; 2018; 51(5):2111-2122. PubMed ID: 30522100
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
